Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. (Q38324836)

2 September 2017

Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. (English)

1 reference

2 September 2017

0 references

Philippe Gosset

2

0 references

Muriel Moser

12

object named as

Muriel Moser

1 reference

2 September 2017

9

Bart Lambrecht

1 reference

2 September 2017

Christophe Desmet

1

1 reference

2 September 2017

Emmanuelle Henry

3

1 reference

2 September 2017

Virginie Garzé

4

1 reference

2 September 2017

Pedro Faisca

5

1 reference

2 September 2017

Nanda Vos

6

1 reference

2 September 2017

Fabrice Jaspar

7

1 reference

2 September 2017

Dorothée Mélotte

8

1 reference

2 September 2017

Daniel Desmecht

10

1 reference

2 September 2017

Bernard Pajak

11

1 reference

2 September 2017

Pierre Lekeux

13

1 reference

2 September 2017

Fabrice Bureau

14

1 reference

2 September 2017

language of work or name

English

0 references

publication date

16 June 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

2 September 2017

1 reference

2 September 2017

172

1 reference

2 September 2017

6

1 reference

2 September 2017

671-678

1 reference

Immunologic basis of antigen-induced airway hyperresponsiveness

2 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

The role of T lymphocytes in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Transcription factors and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Th2 cell-specific cytokine expression and allergen-induced airway inflammation depend on JunB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

JunD regulates lymphocyte proliferation and T helper cell cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Therapeutic applications of transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Effect of somatic growth, strain, and sex on double-chamber plethysmographic respiratory function values in healthy mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

AP-1 as a regulator of cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Asthma. From bronchoconstriction to airways inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Transcriptional regulation of the IL-5 gene in peripheral T cells of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Impaired development of Th2 cells in IL-13-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Requirement for IL-13 independently of IL-4 in experimental asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Interleukin-13: central mediator of allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

2. Cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

New directions in allergic diseases: mechanism-based anti-inflammatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Glucocorticoids: new mechanisms and future agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Glucocorticoid-regulated transcription factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

β-Adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Molecular mechanisms of anti-inflammatory action of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200410-1431OC

10.1164/RCCM.200410-1431OC

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference